OmegaMore

Company Overview

Snapshot

Founded in January 2013 by Israel Galmor, OmegaMore operates with 1–10 employees. The company has raised $75,000 across one funding round from one investor. In January 2019, OmegaMore secured funding from ExitValley.

Business overview

OmegaMore develops, manufactures, and markets omega-3 supplements derived from sea algae. The company's core product is a formula designed to treat and prevent cognitive diseases such as Alzheimer's, depression, and ADHD, as well as heart and liver malfunctions and metastatic cancer. The algae used are cultivated in freshwater ponds, mimicking their natural environment while avoiding pollution. OmegaMore operates within the Health Tech & Life Sciences sector, specifically targeting pharmaceuticals and consumers, with a mission to improve quality of life by enhancing omega-3 fatty acid concentration to alleviate brain and cardiovascular disorders.

Company Intelligence Q&A

What is OmegaMore's primary focus?

OmegaMore focuses on developing, manufacturing, and marketing omega-3 supplements extracted from sea algae, specifically targeting the treatment and prevention of chronic cognitive diseases and cardiovascular issues.

Who founded OmegaMore?

OmegaMore was founded by Israel Galmor.

When was OmegaMore founded?

OmegaMore was founded in January 2013.

What is the source of OmegaMore's omega-3 supplements?

OmegaMore's omega-3 supplements are extracted from sea algae, which are grown in freshwater ponds with added salts and minerals to simulate their natural environment, ensuring purity from pollution or heavy metals.

What type of diseases does OmegaMore's product aim to address?

OmegaMore's product is designed to address cognitive diseases such as Alzheimer's, depression, and ADHD, as well as heart and liver malfunctions and metastatic cancer.